Procurement team and The Calvert Trust

As you know we have been working with The Calvert Trust which enables people with disabilities, together with their families and friends, to achieve their potential through the challenge of...

Read more


Actavis UK & Ireland are now Accord Healthcare

Actavis UK & Ireland have rebranded to become Accord Healthcare

Read more


Intas completes deal

Intas Pharmaceuticals completes deal to acquire Actavis UK & Ireland generics businesses. 

Read more


Imatinib Accord Launch

Accord Healthcare launches Imatinib Accord 100 mg and 400 mg in the UK.

Accord Healthcare launches Imatinib Accord[1] in the UK, a tyrosine-kinase inhibitor indicated for the treatment...

Read more


Intas recent acquisition

Intas Pharmaceuticals acquires the generics business of Actavis in the UK & Ireland

Read more


Aripiprazole Accord Launch

Accord Healthcare is delighted to announce the launch of Aripiprazole Accord, generic version of Abilify®. The product is available in 5, 10, 15 and 30 mg presentations in packs of 28 tablets...

Read more


Clinigen Group Extends Exclusive Agreement with Accord Healthcare to Supply Anti-Cancer Drug Capecitabine into Clinical Trials in Europe

Burton-on-Trent, UK – 14 January 2014 – Clinigen Group plc (AIM: CLIN) today announced that its Clinical Trials Supply business (Clinigen CTS) has extended its exclusive European Union (EU)...

Read more


Clinigen Group extends agreement to exclusively supply clinical trials with Accord Healthcare’s EU Oncology Products

Burton-on-Trent, UK – 20 June 2013 – Clinigen Group plc (‘Clinigen’ or the ‘Group’) (AIM: CLIN) today announced that Clinigen Clinical Trial Supply (‘CTS’) has extended its exclusive clinical...

Read more


Accord Healthcare Ltd. has successfully resolved the case against AstraZeneca relating to the validity of the patent covering quetiapine ER (Seroquel®


A Judgment in the case was handed down by the Court of Appeal on the 30th of April and confirms the decision of the UK High Court in March 2012 that AstraZeneca’s patent is...

Read more